Close Menu
    What's Hot

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      AIR Asset Management’s Taylor Garvey Joins LISA Board, Promoted to Managing Director

      January 19, 2026

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    The Dangers of Defaulting to Fast Track

    Longevity and Mortality Risk Transfer July 16, 2025By David Hamilton
    Share
    Twitter LinkedIn Email

    Fast track… sounds appealing, doesn’t it? What trustee board, overloaded with governance documents and new valuation requirements, wouldn’t be attracted to an option that promises to save time and reduces enquiries about their work? But a name can be deceptive, and hundreds of DB arrangements could be about to sleepwalk into adding a material and unnecessary financial burden on their sponsoring employers.

    For the majority of schemes, given the positive funding news in recent years, it will probably be perfectly sensible to head straight for fast track. They are well funded and in a low-risk investment strategy already, or so close as to make minimal difference, so they meet the criteria without even trying. For them it’s a simple case of ticking the relevant boxes and away you go.

    At the other end of the scale, some know that they won’t have the option to consider fast track. Their recovery plan is too long to qualify, or they are reliant on (or committed to) a higher risk investment strategy.

    For a significant number of schemes in between, the position is rather more complicated. Nevertheless, the temptation to reach blindly for the ‘quick and easy’ option is high, particularly for smaller schemes. This could result in requests for contributions from sponsors that are not strictly required, and lower returning investment strategies being implemented.

    This, in turn, has the potential consequence of slowing the path to buyout, leading to additional running costs or potentially even preventing discretionary benefits being awarded to members.

    Let’s look at this another way. Suppose instead of ‘bespoke’ and ‘fast track’ these were described as the Regulator’s ‘basic’ or ‘premium’ approval service. Essentially the Regulator is saying that if you’re willing to pay a bit more money into your scheme and take a less risky approach then they will ask you fewer questions and expedite your valuation signoff. Fair enough, but the different labelling would, I suspect, mean many more schemes would default their discussions to the ‘basic’ service. Crucially, they would also ask how much it costs to upgrade to the ‘premium’ service before rushing towards that option.

    Let’s just take one simple example based on a recent case. The trustees were historically funding on a ‘gilts + 1%’ approach, with a diversified investment portfolio hedging all of their key investment risks. Their funding had improved so they would have a small surplus on their old valuation basis but the temptation was strong – let’s just go fast track so that it’s all a bit easier.

    So, the numbers were run accordingly, including the required expense reserve. Amend the discount rate tweak a few other areas for fast track compliance and suddenly their liabilities were 4% higher. Just like that, the surplus had been eliminated and a request was going to the sponsor for additional money. I suspect you can picture the scene in the boardroom:

    Chair of Trustees – “We need more money into the scheme.”

    Finance Director (Employer) – “What? Why? I thought the scheme was in surplus?”

    In this instance, the diplomatic, if not entirely correct, response given is: “The Regulator’s new funding regime required us to add more prudence,” eliciting the inevitable grumble from the other side of the table. But what if the Trustee had said, “We just decided to opt for the Regulator’s premium service so that we could make the reporting a bit easier. We didn’t think you’d mind, and it means the Scheme will be even more secure”? I suspect the Employer’s response in that scenario, after battling through years of deficit contributions, may have been rather more challenging!

    There is of course a balance to be struck. No one can deny that there will be advisory costs associated with the additional reporting for bespoke submissions. But how many tens (or even hundreds) of thousands of pounds is it worth sponsors paying to avoid that?

    And do you really expect a lot of engagement once you’ve submitted the new Statement of Strategy summary document to the Regulator if you can describe a reasonable approach? I suspect that some lay trustees may quake in fear at the thought of being summoned into the presence of TPR, the almighty Wizard(s) of Brighton. However, those who have seen behind the curtain and understand the Regulator is juggling piles of casework, often with much larger schemes needing its attention, may be somewhat more relaxed. As long as they have been through a reasonable process, of course. After all, they probably already know they’ll have a stronger, and more supportive, employer to work through it with them.

    And remember, much of the ‘extra work’ that you will be reporting on for bespoke cases is still expected to be part of the trustees’ process (proportionate assessment of the employer covenant etc.). It’s just that it isn’t disclosed in the fast track scenario. Sure, there will be some trustees who decide to take short cuts (if no one’s marking the homework then will you really do it to the same standard?) but this should be actively decided on as part of the process. Otherwise, they face exposure if, heaven forbid, something major does go wrong or if the Regulator just happens to do one of its spot checks.

    So, if you are one of those schemes who genuinely have a decision to make on which route to go down with your first valuation under the new regime, I challenge you to pause. If these were called ‘basic’ and ‘premium’ services rather than ‘bespoke’ and ‘fast track’ would you be quite so quick to blindly jump on the ‘fast track’ bandwagon?

    David Hamilton is Chief Actuary at Broadstone


    Footnotes:

    Any views expressed in this article are those of the author(s) and may not necessarily represent those of Life Risk News or its publisher, the European Life Settlement Association

    2025 - July Commentary Longevity Risk Pension Risk Transfer Volume 4 Issue 7 – July 2025
    Share. Twitter LinkedIn Email

    Related Posts

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026By LMI Newsdesk

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026By LMI Newsdesk

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026By LMI Newsdesk

    The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

    February 9, 2026By LMI Newsdesk
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.